Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,574 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Genomic profiling reveals heterogeneous populations of ductal carcinoma in situ of the breast.
Nagasawa S, Kuze Y, Maeda I, Kojima Y, Motoyoshi A, Onishi T, Iwatani T, Yokoe T, Koike J, Chosokabe M, Kubota M, Seino H, Suzuki A, Seki M, Tsuchihara K, Inoue E, Tsugawa K, Ohta T, Suzuki Y. Nagasawa S, et al. Among authors: ohta t. Commun Biol. 2021 Apr 1;4(1):438. doi: 10.1038/s42003-021-01959-9. Commun Biol. 2021. PMID: 33795819 Free PMC article.
Putative tumor suppressor EDD interacts with and up-regulates APC.
Ohshima R, Ohta T, Wu W, Koike A, Iwatani T, Henderson M, Watts CK, Otsubo T. Ohshima R, et al. Among authors: ohta t. Genes Cells. 2007 Dec;12(12):1339-45. doi: 10.1111/j.1365-2443.2007.01138.x. Genes Cells. 2007. PMID: 18076571 Free article.
[Breast cancer].
Ohta T. Ohta T. Nihon Rinsho. 2010 Aug;68 Suppl 8:438-43. Nihon Rinsho. 2010. PMID: 20976920 Review. Japanese. No abstract available.
NF-κB signaling mediates acquired resistance after PARP inhibition.
Nakagawa Y, Sedukhina AS, Okamoto N, Nagasawa S, Suzuki N, Ohta T, Hattori H, Roche-Molina M, Narváez AJ, Jeyasekharan AD, Bernal JA, Sato K. Nakagawa Y, et al. Among authors: ohta t. Oncotarget. 2015 Feb 28;6(6):3825-39. doi: 10.18632/oncotarget.2868. Oncotarget. 2015. PMID: 25686825 Free PMC article.
MED12 exon 2 mutations in phyllodes tumors of the breast.
Nagasawa S, Maeda I, Fukuda T, Wu W, Hayami R, Kojima Y, Tsugawa K, Ohta T. Nagasawa S, et al. Among authors: ohta t. Cancer Med. 2015 Jul;4(7):1117-21. doi: 10.1002/cam4.462. Epub 2015 Apr 13. Cancer Med. 2015. PMID: 25865354 Free PMC article.
Fbxo22-mediated KDM4B degradation determines selective estrogen receptor modulator activity in breast cancer.
Johmura Y, Maeda I, Suzuki N, Wu W, Goda A, Morita M, Yamaguchi K, Yamamoto M, Nagasawa S, Kojima Y, Tsugawa K, Inoue N, Miyoshi Y, Osako T, Akiyama F, Maruyama R, Inoue JI, Furukawa Y, Ohta T, Nakanishi M. Johmura Y, et al. Among authors: ohta t. J Clin Invest. 2018 Dec 3;128(12):5603-5619. doi: 10.1172/JCI121679. Epub 2018 Nov 12. J Clin Invest. 2018. PMID: 30418174 Free PMC article.
Potential role of Fbxo22 in resistance to endocrine therapy in breast cancer with invasive lobular carcinoma.
Nakagawa S, Miyashita M, Maeda I, Goda A, Tada H, Amari M, Kojima Y, Tsugawa K, Ohi Y, Sagara Y, Sato M, Ebata A, Harada-Shoji N, Suzuki T, Nakanishi M, Ohta T, Ishida T. Nakagawa S, et al. Among authors: ohta t. Breast Cancer Res Treat. 2024 Apr;204(3):453-463. doi: 10.1007/s10549-023-07209-2. Epub 2024 Jan 5. Breast Cancer Res Treat. 2024. PMID: 38180699 Free PMC article.
3,574 results